Standard Neoadjuvant Treatment in Early/Locally Advanced Breast Cancer.

dc.contributor.authorPernaut, Cristina
dc.contributor.authorLopez, Flora
dc.contributor.authorCiruelos, Eva
dc.date.accessioned2025-01-07T13:20:15Z
dc.date.available2025-01-07T13:20:15Z
dc.date.issued2018-08-03
dc.description.abstractNeoadjuvant treatment allows us to improve surgical results and test new drugs. In recent years, there have been significant advances in the field of neoadjuvant treatment, including hormonal neoadjuvant therapy in luminal tumors, double blockade in HER2-positive tumors, and the use of platinum salts in triple-negative tumors.
dc.identifier.doi10.1159/000491759
dc.identifier.issn1661-3791
dc.identifier.pmcPMC6170899
dc.identifier.pmid30319326
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC6170899/pdf
dc.identifier.unpaywallURLhttps://www.karger.com/Article/Pdf/491759
dc.identifier.urihttps://hdl.handle.net/10668/25445
dc.issue.number4
dc.journal.titleBreast care (Basel, Switzerland)
dc.journal.titleabbreviationBreast Care (Basel)
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.page.number244-249
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rights.accessRightsopen access
dc.subjectBreast cancer
dc.subjectNeoadjuvant treatment
dc.subjectPathological complete response
dc.titleStandard Neoadjuvant Treatment in Early/Locally Advanced Breast Cancer.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number13

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC6170899.pdf
Size:
85.87 KB
Format:
Adobe Portable Document Format